Viewing Study NCT02960906


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2026-02-27 @ 12:48 AM
Study NCT ID: NCT02960906
Status: COMPLETED
Last Update Posted: 2021-04-26
First Post: 2016-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer
Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-05-31
Start Date Type: ACTUAL
Primary Completion Date: 2021-02-15
Primary Completion Date Type: ACTUAL
Completion Date: 2021-02-15
Completion Date Type: ACTUAL
First Submit Date: 2016-08-18
First Submit QC Date: None
Study First Post Date: 2016-11-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-04-22
Last Update Post Date: 2021-04-26
Last Update Post Date Type: ACTUAL